1Life Healthcare
ONEM
ONEM was delisted on the 21st of February, 2023.
222 hedge funds and large institutions have $3B invested in 1Life Healthcare in 2022 Q3 according to their latest regulatory filings, with 87 funds opening new positions, 53 increasing their positions, 51 reducing their positions, and 52 closing their positions.
712% more call options, than puts
Call options by funds: $86.2M | Put options by funds: $10.6M
135% more capital invested
Capital invested by funds: $1.28B → $3B (+$1.72B)
86% more funds holding in top 10
Funds holding in top 10: 7 → 13 (+6)
67% more first-time investments, than exits
New positions opened: 87 | Existing positions closed: 52
19% more funds holding
Funds holding: 187 → 222 (+35)
4% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 51
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
+$122M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$105M |
| 3 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$87.4M |
| 4 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$79.1M |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$62.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Tiger Global Management
New York
|
-$133M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$112M |
| 3 |
ATGP
Addition Three General Partner
New York
|
-$108M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$57.8M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$52.6M |
ONEM Hedge Fund Activity: Q3 2022 in Review
222 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in 1Life Healthcare (ONEM) for Q3 2022, worth a combined $3B — up 135% from $1.28B a quarter earlier.
Buyers outnumbered sellers: 87 funds opened new ONEM positions and 52 closed out — a net gain of 35 holders — while 53 added to existing stakes and 51 trimmed.
The largest buyer was Fidelity International, opening a new position worth an estimated $122M. The largest seller was Tiger Global Management, exiting entirely with an estimated $133M sold.
- 222 institutional investors held 1Life Healthcare (ONEM) as of Q3 2022, up from 187 in Q2 2022.
- Funds reported $3B of 1Life Healthcare stock for Q3 2022, up 135% quarter-over-quarter.
- 87 funds opened new 1Life Healthcare positions in Q3 2022 and 52 closed out, a net change of +35 holders.
- The largest 1Life Healthcare buyer in Q3 2022 was Fidelity International, an estimated $122M added.
- The largest 1Life Healthcare seller in Q3 2022 was Tiger Global Management, an estimated $133M sold.
Based on aggregated 13F filings for Q3 2022.